Keywords: acamprosate, uk, application, filed, lipha, pharmaceuticals, submitted

Acamprosate UK Application Filed

Article | 20 March 1995

Lipha Pharmaceuticals has submitted a license application for its gamma-aminobutyric acid agonist Campral (acamprosate) in the UK for the long-term ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Acamprosate Calcium

Campral

Go to drug listing